Extracorporeal Femoro-Carotid Shunt for Transcarotid Transcatheter Aortic Valve Replacement

Robert Semco1, Ross G McFall2, Jay Khambhati3

  • 1Harvard Medical School, Boston, Massachusetts, USA.

JACC. Case Reports
|May 23, 2024
PubMed

Insights

Transcatheter aortic valve replacement (TAVR) can be done via a transcarotid route if transfemoral access is not possible. A temporary shunt enabled successful TAVR in a patient experiencing electroencephalographic changes during the procedure.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Neurology

Background:

  • Transcatheter aortic valve replacement (TAVR) is an alternative to surgical aortic valve replacement for severe aortic stenosis.
  • Transfemoral access is the standard TAVR approach, but peripheral vascular disease can preclude its use.
  • The transcarotid approach offers an alternative route for TAVR when transfemoral access is not feasible.

Observation:

  • A patient with severe aortic stenosis presented in cardiogenic shock.
  • Electroencephalographic (EEG) changes were noted during a transcarotid TAVR procedure.
  • These changes suggested potential cerebral hypoperfusion or embolic events.

Findings:

  • A temporary extracorporeal femoro-carotid shunt was implemented during the transcarotid TAVR.
  • The shunt successfully maintained cerebral perfusion and facilitated the completion of the TAVR procedure.
  • Hemodynamic stability and neurological status improved post-procedure.

Implications:

  • Temporary extracorporeal shunting is a viable strategy to manage intraprocedural complications during transcarotid TAVR.
  • This technique may improve outcomes for high-risk patients undergoing TAVR via alternative access routes.
  • Further research is warranted to evaluate the safety and efficacy of femoro-carotid shunts in TAVR.

Related Concept Videos